Table 7.
Participants | Experimental Design Phase | Plasma Osmolality (mOsm/kg H2O) | Plasma AVP (pg/ml) | Reference |
---|---|---|---|---|
8 ♀ b (21–34 year) |
Baseline, EU | 289 ± 2 | 1.3 ± 0.6 | Davison et al., AJP 1984 [62] |
12-h WR c | 294 ± 2 | 2.9 ± 1.2 | ||
5 ♂ & 3 ♀ b (26–50 year) |
Baseline, EU | 292 ± 1 | 1.7 ± 0.2 | Geelen et al., AJP 1984 [63] |
24-h WR c | 302 ± 1 | 3.3 ± 0.5 | ||
7 ♂ (20–31 year) |
Baseline, EU | 288 ± 1 | 1.0 ± 0.3 | Phillips et al., NEJM 1984 [88] |
24-h WR c,d | 291 ± 1 | 3.5 ± 0.3 | ||
7 ♂ (67–75 year) |
Baseline, EU | 288 ± 1 | 1.8 ± 0.3 | Phillips et al., NEJM 1984 [88] |
24-h WR c,d | 296 ± 1 | 8.3 ± 0.3 |
a, diets included no water or beverages and dry food items; b, nonpregnant women; c, 24-h total water intake was not measured; d, body mass loss was 1.8–1.9% of the baseline value; Abbreviations: AVP, arginine vasopressin; EU, euhydrated; WR, water restriction.